Based on a previous report in which Pirin expression significantly varied between metastasis patients and non-metastasis patients [87], Shubbar et al. showed that Pirin levels in normal breast cells do not differ from invasive breast cancer samples. The gene discussed is PIR; the disease is invasive breast carcinoma.